OpenAI acquires Orchestra Bio, expands life sciences push

T1Covered by 1 source · first reported by The Hindu — Technology / BusinessLine — Info-tech at 21 Oct, 05:21 UTC

The acquisition will integrate Orchestra Bio’s drug development coordination platform with OpenAI’s Rosalind suite, aiming to help scientists manage complex workflows and accelerate the development of new medicines.